FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I: 
, as well as their pharmaceutically acceptable salts and N-oxides.
EFFECT: provides new compounds of formula I, as well as pharmaceutical compositions containing them and their use for agonizing or partial agonizing of dopamine D1 receptors.
17 cl, 10 tbl, 216 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHENOXYPYRIDINYLAMIDE DERIVATIVES, AND THEIR USE IN TREATMENT OF PDE4-MEDIATED DISEASE STATES | 2009 |
|
RU2509077C2 |
| FURO[3,2-B]- AND THIENO[3,2-B]PYRIDINE DERIVATIVES AS TBK1 AND IKKε INHIBITORS | 2013 |
|
RU2622034C2 |
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
| KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
| C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
| POLYHETEROCYCLIC COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | 2005 |
|
RU2381226C2 |
| NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
| PROTEIN TYROSINE KINASE ACTIVITY INHIBITORS | 2009 |
|
RU2533827C2 |
| DERIVATIVE BASED ON DIHYDROPYRIMIDO-RING AS HBV INHIBITOR | 2015 |
|
RU2693897C2 |
| BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | 2016 |
|
RU2684324C1 |
